These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16118377)

  • 1. Risk of death with nesiritide.
    Burger AJ
    JAMA; 2005 Aug; 294(8):897; author reply 898. PubMed ID: 16118377
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure.
    Gerhard T; Zineh I; Winterstein AG; Hartzema AG
    Pharmacotherapy; 2006 Jan; 26(1):34-43. PubMed ID: 16509026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant use of nesiritide and milrinone in decompensated congestive heart failure.
    Smull DL; Jorde UP
    Am J Health Syst Pharm; 2005 Feb; 62(3):291-5. PubMed ID: 15719588
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of death associated with nesiritide in patients with acutely decompensated heart failure.
    Aaronson KD; Sackner-Bernstein J
    JAMA; 2006 Sep; 296(12):1465-6. PubMed ID: 17003394
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of death with nesiritide.
    Gortney JS; Porter KB
    JAMA; 2005 Aug; 294(8):897-8; author reply 898. PubMed ID: 16118376
    [No Abstract]   [Full Text] [Related]  

  • 6. Nesiritide - not verified.
    Topol EJ
    N Engl J Med; 2005 Jul; 353(2):113-6. PubMed ID: 16014879
    [No Abstract]   [Full Text] [Related]  

  • 7. Nesiritide vs nitroglycerin for decompensated congestive heart failure.
    Dunavant S
    JAMA; 2002 Aug; 288(5):571-2; author reply 572-3. PubMed ID: 12150661
    [No Abstract]   [Full Text] [Related]  

  • 8. Nesiritide, heart failure, and renal dysfunction: irrational exuberance or throwing the baby out with the bathwater. Editorial to: "Impact of nesiritide on renal function and mortality in patients suffering from heart failure" by Dontas et al.
    Witteles RM
    Cardiovasc Drugs Ther; 2009 Jun; 23(3):183-6. PubMed ID: 19353257
    [No Abstract]   [Full Text] [Related]  

  • 9. Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure.
    Ma X; Sun F; Ma J
    Int J Cardiol; 2015; 187():387-8. PubMed ID: 25841132
    [No Abstract]   [Full Text] [Related]  

  • 10. Nesiritide vs nitroglycerin for decompensated congestive heart failure.
    Rifkin W
    JAMA; 2002 Aug; 288(5):572; author reply 572-3. PubMed ID: 12150662
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Critical review and recommendations for nesiritide use in the Emergency Department.
    Levine M
    J Emerg Med; 2007 Feb; 32(2):207-8; author reply 208-9. PubMed ID: 17307636
    [No Abstract]   [Full Text] [Related]  

  • 12. Nesiritide--not verified.
    Schreiner G
    N Engl J Med; 2005 Oct; 353(14):1525-7; author reply 1525-7. PubMed ID: 16211709
    [No Abstract]   [Full Text] [Related]  

  • 13. [Does nesiritide reduce dyspnea in decompensated heart failure?].
    Bernardo WM; Moreira FT
    Rev Assoc Med Bras (1992); 2012; 58(1):11-3. PubMed ID: 22392308
    [No Abstract]   [Full Text] [Related]  

  • 14. The lost decade of nesiritide.
    Topol EJ
    N Engl J Med; 2011 Jul; 365(1):81-2. PubMed ID: 21732841
    [No Abstract]   [Full Text] [Related]  

  • 15. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
    Noviasky JA
    Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
    DeWald TA; Hernandez AF
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.
    Wang XC; Zhu DM; Shan YX
    Am J Cardiovasc Drugs; 2015 Dec; 15(6):429-37. PubMed ID: 26123415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nesiritide in heart failure: commercial success or therapeutic advance?].
    Stampfli T; Perrier A
    Rev Med Suisse; 2006 Jan; 2(50):295-8. PubMed ID: 16503047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesiritide: trials and tribulations.
    Arora RR
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):165-9. PubMed ID: 17056828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.
    Sackner-Bernstein JD; Kowalski M; Fox M; Aaronson K
    JAMA; 2005 Apr; 293(15):1900-5. PubMed ID: 15840865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.